Backer Marianne de's Net Worth
$6.75 Million
Who is Backer Marianne de?
Backer Marianne de has an estimated net worth of $6.75 Million. This is based on reported shares across multiple companies, which include Kronos Bio, Inc., ARROWHEAD PHARMACEUTICALS, INC., and Vir Biotechnology, Inc..
SEC CIK
Backer Marianne de's CIK is 0001797819
Past Insider Trading and Trends
2020 was Backer Marianne de's most active year for acquiring shares with 11 total transactions. Backer Marianne de's most active month to acquire stocks was the month of December. 2022 was Backer Marianne de's most active year for disposing of shares, totalling 3 transactions. Backer Marianne de's most active month to dispose stocks was the month of December. 2020 saw Backer Marianne de paying a total of $184,705.00 for 12,500 shares, this is the most they've acquired in one year. In 2021 Backer Marianne de cashed out on 5,000 shares for a total of $449,250.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kronos Bio, Inc. (KRON) Snapshot price: $1.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +412.11% | 11.33K |
—
|
—
| 14.08K |
Jun 22
| |||
Form 4
| +71.88% | 1.15K |
$11.57 | $13,305.50 | 2.75K |
Dec 1
| |||
Form 4
| +166.67% | 1K |
$19.57 | $19,565.00 | 1.6K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 600 |
$25.01 | $15,006.00 | 600 |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Snapshot price: $31.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.62% | 7.87K |
—
|
—
| 31.27K |
Jan 10
| |||
Form 4
| +37.65% | 6.4K |
—
|
—
| 23.4K |
Jan 7
| |||
Form 4
| -20.93% | -4.50K |
$64.71 | -$291,176.84 | 17K |
Jan 3
| |||
Form 4
| -18.87% | -5.00K |
$89.85 | -$449,250.00 | 21.5K |
Jun 24
| |||
Form 4
| +51.43% | 9K |
—
|
—
| 26.5K |
Jan 1
| |||
Form 4
| +6.06% | 1K |
$50.47 | $50,465.00 | 17.5K |
Oct 8
| |||
Form 4
| +32.00% | 4K |
$33.56 | $134,240.00 | 16.5K |
Jan 13 - Jun 15
| |||
Form 4
| +150.00% | 7.5K |
—
|
—
| 12.5K |
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vir Biotechnology, Inc. (VIR) Snapshot price: $9.115
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 678.46K |
Jun 12
| |||
Form 4
| -9.71% | -73.00K |
$9.46 | -$690,364.81 | 678.46K |
Scheduled
|
Apr 3
| ||
Form 4
| +30.36% | 175K |
—
|
—
| 751.45K |
Feb 22
| |||
Form 4
|
∞
| 576.45K |
—
|
—
| 576.45K |
Apr 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||